Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03470805 |
|---|---|
| Brief Title: | Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma |
| First Submitted : | February 28, 2018 |
| First Submitted that Met QC Criteria : | March 19, 2018 |
| First Posted : | March 20, 2018 |
| Last Update Submitted that Met QC Criteria : | September 22, 2022 |
| Last Update Posted : | September 23, 2022 |